Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)
CUSIP: 501976104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 56,833,213
- Total 13F shares
- 31,935,411
- Share change
- +1,243,689
- Total reported value
- $239,516,646
- Put/Call ratio
- 231%
- Price per share
- $7.50
- Number of holders
- 87
- Value change
- -$86,044,405
- Number of buys
- 60
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 501976104?
CUSIP 501976104 identifies KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501976104:
Top shareholders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC |
13F
|
Company |
8%
|
4,523,924
|
$112,374,272 | — | 31 Mar 2024 | |
| Northpond Ventures, LLC |
13F
|
Company |
5.7%
|
3,255,426
|
$80,864,782 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
5.6%
|
3,163,868
|
$78,590,481 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.3%
|
1,852,711
|
$46,021,341 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.6%
|
1,462,337
|
$36,324,451 | — | 31 Mar 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.5%
|
1,398,659
|
$34,742,687 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
929,634
|
$23,093,000 | — | 31 Mar 2024 | |
| Insight Holdings Group, LLC |
13F
|
Company |
1.6%
|
912,915
|
$22,676,809 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
|
Company |
1.6%
|
912,189
|
$22,658,775 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
844,465
|
$20,976,510 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
749,966
|
$18,629,155 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
13F
|
Company |
1.2%
|
700,000
|
$17,388,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
695,094
|
$17,266,135 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.1%
|
606,500
|
$15,041,200 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
601,436
|
$14,939,670 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
575,000
|
$14,283,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.92%
|
523,743
|
$13,009,776 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.88%
|
500,000
|
$12,420,000 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.84%
|
475,827
|
$11,819,543 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.84%
|
475,000
|
$11,799,000 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.81%
|
460,561
|
$11,440,335 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.79%
|
450,000
|
$11,178,000 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.77%
|
440,000
|
$10,929,600 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.69%
|
392,928
|
$9,760,332 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.46%
|
264,215
|
$6,563,101 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.36%
|
202,333
|
$5,025,952 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.35%
|
200,000
|
$4,968,000 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
178,963
|
$4,445,441 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
172,236
|
$4,279,742 | — | 31 Mar 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.29%
|
166,514
|
$4,136,208 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
155,755
|
$3,868,955 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.26%
|
150,000
|
$3,726,000 | — | 31 Mar 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.26%
|
150,000
|
$3,726,000 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.26%
|
150,000
|
$3,726,000 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.26%
|
150,000
|
$3,726,000 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.19%
|
105,900
|
$2,630,556 | — | 31 Mar 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.18%
|
104,814
|
$2,603,580 | — | 31 Mar 2024 | |
| Blackstone Inc. |
13F
|
Company |
0.18%
|
100,000
|
$2,484,000 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.18%
|
100,000
|
$2,484,000 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.16%
|
88,423
|
$2,196,427 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
84,880
|
$2,108,419 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.13%
|
75,865
|
$1,884,487 | — | 31 Mar 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.12%
|
70,000
|
$1,738,800 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.12%
|
69,237
|
$1,719,847 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.11%
|
65,000
|
$1,614,600 | — | 31 Mar 2024 | |
| Point72 (DIFC) Ltd |
13F
|
Company |
0.11%
|
60,800
|
$1,510,272 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
59,666
|
$1,482,103 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
50,400
|
$1,251,936 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.09%
|
50,000
|
$1,242,000 | — | 31 Mar 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.09%
|
50,000
|
$1,242,000 | — | 31 Mar 2024 |
Institutional Holders of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) as of Q2 2024
As of 30 Jun 2024,
Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,935,411 shares.
The largest 10 holders included
Vida Ventures Advisors, LLC, Bain Capital Life Sciences Investors, LLC, Northpond Ventures, LLC, JPMORGAN CHASE & CO, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RTW INVESTMENTS, LP, Novo Holdings A/S, BlackRock Inc., VANGUARD GROUP INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
88
Q2 2024 holders
87
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.